[On the path to "e-HAART"? Glimpse at salvage therapy].
D019380:Anti-HIV Agents / Q000008:administration & dosage* / Q000009:adverse effects; D023241:Antiretroviral Therapy, Highly Active / Q000639:trends*; D002986:Clinical Trials as Topic; D000077560:Enfuvirtide; D005544:Forecasting; D015700:HIV Envelope Protein gp41 / Q000008:administration & dosage / Q000009:adverse effects; D015658:HIV Infections / Q000188:drug therapy*; D019428:HIV Integrase Inhibitors / Q000008:administration & dosage / Q000009:adverse effects; D006801:Humans; D010446:Peptide Fragments / Q000008:administration & dosage / Q000009:adverse effects; D016879:Salvage Therapy
D019380:Anti-HIV Agents; D015700:HIV Envelope Protein gp41; D019428:HIV Integrase Inhibitors; D010446:Peptide Fragments; D000077560:Enfuvirtide